Ratings Nexam Chemical Holding AB

Equities

NEXAM

SE0005101003

Delayed Nasdaq Stockholm 07:43:15 2024-06-03 am EDT 5-day change 1st Jan Change
3.11 SEK +3.32% Intraday chart for Nexam Chemical Holding AB +2.98% -7.44%

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
-7.44% 23.12M -
-4.45% 19.39B -
-11.50% 5.49B
A-
+4.02% 4.19B
B
+15.88% 1.59B
B
+3.12% 1.31B
B-
+19.82% 959M -
-11.55% 688M - -
-36.36% 566M -
-13.97% 290M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. NEXAM Stock
  4. Ratings Nexam Chemical Holding AB